(5.9) Adverse Reactions/Side Effects The most common adverse reactions reported in 5% of patients simultaneously started on sitagliptin and metformin and more commonly than in patients treated with placebo were diarrhea, upper respiratory tract infection, and headache
The challenge with fatty liver and glutathione lies in the fact that the very condition depleting your glutathione is also making it harder for your liver to produce more
In the next 4 or 5 years, this field will mature and more patients ultimately should be able to get these medicines, Kyle Sloop, a molecular biologist at Lilly Research Laboratories, told Science
Stopping and restarting certain GLP-1s to lose weight may make the drug less effective A preclinical study reveals that people seeking weight loss from GLP-1s may need to consistently take the medication long term
Targeted therapies In recent years, many studies have shown that the composition and diversity of gut microbiota can be beneficially altered by diet, prebiotics, probiotics, and fecal transplantation to confer benefits to the host (Fig
Sleep will be important in this process